1. Home
  2. GNFT vs PROF Comparison

GNFT vs PROF Comparison

Compare GNFT & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • PROF
  • Stock Information
  • Founded
  • GNFT 1999
  • PROF N/A
  • Country
  • GNFT France
  • PROF Canada
  • Employees
  • GNFT 167
  • PROF N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • PROF Medical/Dental Instruments
  • Sector
  • GNFT Health Care
  • PROF Health Care
  • Exchange
  • GNFT Nasdaq
  • PROF Nasdaq
  • Market Cap
  • GNFT 189.6M
  • PROF 186.3M
  • IPO Year
  • GNFT 2019
  • PROF N/A
  • Fundamental
  • Price
  • GNFT $3.80
  • PROF $7.24
  • Analyst Decision
  • GNFT Strong Buy
  • PROF Strong Buy
  • Analyst Count
  • GNFT 1
  • PROF 2
  • Target Price
  • GNFT $13.00
  • PROF $11.40
  • AVG Volume (30 Days)
  • GNFT 9.8K
  • PROF 105.6K
  • Earning Date
  • GNFT 09-19-2024
  • PROF 11-07-2024
  • Dividend Yield
  • GNFT N/A
  • PROF N/A
  • EPS Growth
  • GNFT N/A
  • PROF N/A
  • EPS
  • GNFT 0.47
  • PROF N/A
  • Revenue
  • GNFT $86,225,222.00
  • PROF $8,984,000.00
  • Revenue This Year
  • GNFT $155.44
  • PROF $56.61
  • Revenue Next Year
  • GNFT N/A
  • PROF $160.87
  • P/E Ratio
  • GNFT $7.59
  • PROF N/A
  • Revenue Growth
  • GNFT 175.45
  • PROF 39.35
  • 52 Week Low
  • GNFT $3.31
  • PROF $6.88
  • 52 Week High
  • GNFT $6.42
  • PROF $11.42
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 29.24
  • PROF 40.10
  • Support Level
  • GNFT $3.63
  • PROF $7.00
  • Resistance Level
  • GNFT $3.88
  • PROF $7.40
  • Average True Range (ATR)
  • GNFT 0.10
  • PROF 0.40
  • MACD
  • GNFT 0.02
  • PROF -0.07
  • Stochastic Oscillator
  • GNFT 15.30
  • PROF 15.52

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: